| IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis L Browning, MR Patel, EB Horvath, K Tawara, CL Jorcyk Cancer management and research, 6685-6693, 2018 | 223 | 2018 |
| Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies K Tawara, JT Oxford, CL Jorcyk Cancer management and research, 177-189, 2011 | 215 | 2011 |
| Endoplasmic reticulum stress and unfolded protein response in cartilage pathophysiology; contributing factors to apoptosis and osteoarthritis A Hughes, AE Oxford, K Tawara, CL Jorcyk, JT Oxford International journal of molecular sciences 18 (3), 665, 2017 | 92 | 2017 |
| Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation C Bolin, K Tawara, C Sutherland, J Redshaw, P Aranda, J Moselhy, ... Genes & cancer 3 (2), 117-130, 2012 | 90 | 2012 |
| HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β K Tawara, H Scott, J Emathinger, C Wolf, D LaJoie, D Hedeen, L Bond, ... Oncotarget 10 (21), 2068, 2019 | 53 | 2019 |
| OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung K Tawara, C Bolin, J Koncinsky, S Kadaba, H Covert, C Sutherland, ... Breast Cancer Research 20, 1-18, 2018 | 51 | 2018 |
| Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis RE Ryan, B Martin, L Mellor, RB Jacob, K Tawara, OM McDougal, ... Cytokine 72 (1), 71-85, 2015 | 49 | 2015 |
| Co-expression of VEGF and IL-6 family cytokines is associated with decreased survival in HER2 negative breast cancer patients: subtype-specific IL-6 family cytokine-mediated … K Tawara, H Scott, J Emathinger, A Ide, R Fox, D Greiner, D LaJoie, ... Translational oncology 12 (2), 245-255, 2019 | 45 | 2019 |
| Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology D Mikelonis, CL Jorcyk, K Tawara, JT Oxford Orphanet journal of rare diseases 9, 1-11, 2014 | 38 | 2014 |
| Experimental versus numerical data for breast cancer progression CL Jorcyk, M Kolev, K Tawara, B Zubik-Kowal Nonlinear Analysis: Real World Applications 13 (1), 78-84, 2012 | 35 | 2012 |
| Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis C Bolin, C Sutherland, K Tawara, J Moselhy, CL Jorcyk Biological procedures online 14, 1-10, 2012 | 34 | 2012 |
| The effect of OSM on MC3T3-E1 osteoblastic cells in simulated microgravity with radiation J Goyden, K Tawara, D Hedeen, JS Willey, J Thom Oxford, CL Jorcyk PloS one 10 (6), e0127230, 2015 | 22 | 2015 |
| OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition H Covert, LF Mellor, CL Wolf, N Ankenbrandt, JM Emathinger, K Tawara, ... Cancer management and research, 7721-7737, 2019 | 10 | 2019 |
| Oncostatin M promotes breast cancer metastasis to lung by affecting initial stages of metastasis K Tawara, C Bolin, J Koncinsky, CL Jorcyk Cancer Research 75 (15_Supplement), 2276-2276, 2015 | 2 | 2015 |
| Oncostatin M Induces Barrier Dysfunction in Human Brain Microvascular Endothelium via Snail‐Dependent Repression of TAMPs TS Wertz, BA Hoettels, K Tawara, JT Oxford, CL Jorcyk, RS Beard Jr The FASEB Journal 31, 679.9-679.9, 2017 | 1 | 2017 |
| Differential expression of VEGF in breast cancer cells induced by gp130 cytokines DS Hedeen, K Tawara, M Nandakumar, R Fox, D Chang, A Ide, A Oler, ... Cancer Research 75 (15_Supplement), 4183-4183, 2015 | 1 | 2015 |
| Mechanisms of oncostatin M (OSM)-mediated breast cancer metastasis to bone: Evidence for a role in osteoclastogenesis CM Bolin, K Tawara, C Sutherland, R Anderson, C Jorcyk Cancer Research 71 (8_Supplement), 1469-1469, 2011 | 1 | 2011 |
| A role for oncostatin M in breast cancer metastasis to bone K Tawara, C Bolin, C Sutherland, RL Anderson, CL Jorcyk CLINICAL & EXPERIMENTAL METASTASIS 28 (2), 190-191, 2011 | 1 | 2011 |
| Understanding the differential role of an IL-6 family cytokine in varying subtypes of breast cancer patients for novel therapeutic intervention CL Wolf, K Tawara, CL Jorcyk Cancer Research 84 (6_Supplement), 1389-1389, 2024 | | 2024 |
| Abstract B045: Novel Small Molecule Inhibitors Targeting Proinflammatory Cytokines in Metastatic Breast Cancer CL Wolf, C Pruett, D Lighter, C McGrath, A Feci, J Tuccinardi, S Dinca, ... Cancer Research 84 (3_Supplement_1), B045-B045, 2024 | | 2024 |
Julia OxfordBoise State University, Biochemistry & BiophysicsE-mail confirmado em boisestate.edu
